Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Escitalopram 20 mg Film-coated Tablets in Healthy Thai Volunteers
TCTR20220723001Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of escitalopram (2 arms), sponsored by International Bio Service. Primary endpoint: Primary pharmacokinetic bioequivalence parameters. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
escitalopram
Beyond the preview
Go deeper on TCTR20220723001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220723001.